Johnson & Johnson - Company Profile
Powered by
All the data and insights you need on Johnson & Johnson in one report.
- Save hours of research time and resources with
our up-to-date Johnson & Johnson Strategy Report
- Understand Johnson & Johnson position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Johnson & Johnson (J&J) researches, develops, manufactures, and sells pharmaceutical products and medical devices. The company conducts business through its operating companies. It provides pharmaceuticals for immune disorders, cancer, neurological disorders, infectious, cardiovascular, and metabolic diseases; and medical devices for use in cardiovascular, orthopaedic, neurovascular care, general surgery and vision care fields. J&J distributes pharmaceutical and medical products to retailers, wholesalers, healthcare professionals and hospitals. The company offers its products in the US; Europe; Asia-Pacific and Africa; and Western Hemisphere (excluding the US) and Latin America. J&J is headquartered in New Brunswick, New Jersey, the US.
Johnson & Johnson premium industry data and analytics
Products and Services
Products | Brands |
---|---|
Pharmaceutical | - |
Immunology: | Johnson’s |
Rheumatoid Arthritis | Listerine |
XYZ | XYZ |
XYZ | XYZ |
XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
Year | Event | Description |
---|---|---|
2024 | Contracts/Agreements | In April, the company signed a deal to acquire Shockwave Medical for US$13.1 billion. |
2024 | Regulatory Approval | In April, the company secured approval from the U.S. Food and Drug Administration for CARVYKTI to treat myeloma. |
2024 | Contracts/Agreements | In April, the company announced a collaboration with 100 community-led organizations to promote health equity. |
Competitor Comparison
Key Parameters | Johnson & Johnson | F. Hoffmann-La Roche Ltd | Merck & Co Inc | Pfizer Inc | Sanofi |
---|---|---|---|---|---|
Headquarters | United States of America | Switzerland | United States of America | United States of America | France |
City | New Brunswick | Basel | Kenilworth | New York | Paris |
State/Province | New Jersey | - | New Jersey | New York | Ile-de-France |
No. of Employees | 131,900 | 103,605 | 72,000 | 88,000 | 87,994 |
Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
Joaquin Duato | Chief Executive Officer; Chairman | Executive Board | 2023 | 61 |
Joseph J. Wolk | Chief Financial Officer; Executive Vice President | Senior Management | 2018 | 57 |
James Swanson | Chief Information Officer; Executive Vice President | Senior Management | 2022 | 58 |
William N. Hait, M.D., Ph. D. | Chief External Innovation and Medical Safety Officer; Executive Vice President | Senior Management | 2022 | 74 |
Kathryn E. Wengel | Chief Technical Operations & Risk Officer; Executive Vice President | Senior Management | 2023 | 58 |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer